Last reviewed · How we verify

NCT03474224: INTAT

Hemodynamic Optimization During Major Urological Surgery

Completed Last updated 7 June 2022
What this trial tests

trial testing Ev1000 Clinical Platform from Edwards Lifesciences in Hemodynamic Instability in 30 participants. Completed in 28 July 2020.

Timeline
5 October 2018
Primary endpoint
21 July 2020
28 July 2020

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date5 October 2018
Primary completion21 July 2020
Estimated completion28 July 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

Adults 18 to 75, any sex, with Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective observational study investigators aim to seek for any possible correlation between the venous to arterial carbon dioxide difference (pCO2 gap) at the end of surgery and the percentage of time spent above a predefined threshold of stroke volume (SV) andn mean arterial pressure (MAP).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemodynamic Instability

Currently open trials in the same condition.

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03474224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing